We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Cytrx Corp. (MM) | NASDAQ:CYTR | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.31 | 0.30 | 0.3001 | 0 | 01:00:00 |
Delaware
|
|
000-15327
|
|
58-1642740
|
(State or other jurisdiction
of incorporation) |
|
(Commission File Number)
|
|
(IRS Employer
Identification No.) |
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Exhibit No.
|
|
Description
|
Employment Agreement by and between CytRx Corporation ("Employer") and Dr. Felix Kratz, Ph.D. ("Employee"), dated March 16, 2018.
|
CYTRX CORPORATION | |||
Date: March 22, 2018
|
By:
|
/s/ JOHN Y. CALOZ | |
John Y. Caloz | |||
Title: Chief Financial Officer | |||
1 Year Cytrx Chart |
1 Month Cytrx Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions